|
| |
Spencer Forrest Begins Clinical Trials On The X5 Hair Laser, Sets Sights On Beating Genetic Hair Loss
Sep 07, 2008 -- In yet another milestone for its line of products aimed at countering hair loss, Spencer Forrest Inc. has officially entered clinical trials with its X5 Hair Laser. Featuring 15 individual lasers that interact directly with the scalp, the X5 is the most powerful Laser Therapy device on the market. It is also the first device to enter clinical trials utilizing individual lasers to ensure maximum user benefits.
|
Spencer Forrest Begins Clinical Trials On The X5 Hair Laser, Sets Sights On Beating Genetic Hair Loss
Sep 07, 2008 -- In yet another milestone for its line of products aimed at countering hair loss, Spencer Forrest Inc. has officially entered clinical trials with its X5 Hair Laser. Featuring 15 individual lasers that interact directly with the scalp, the X5 is the most powerful Laser Therapy device on the market. It is also the first device to enter clinical trials utilizing individual lasers to ensure maximum user benefits.
|
Leading Surgicare Surgeon - Egon Eder - Talks About Revolutionary Breast Augmentation Surgery
Sep 06, 2008 -- Advances in breast surgery have this year hit an all time high, with the introduction of Macrolane to the UK and with the growing popularity of Transaxillary Incision. Both procedures equal great results without unsightly scars. SurgiCare, a leading UK cosmetic surgery provider, is always looking for the next advancement in cosmetic procedures in order to offer patients different options to match different required results.
|
BioCryst Reports Results From BCX-4208 Phase IIa Trial In Subjects With Psoriasis
Sep 05, 2008 -- BioCryst Pharmaceuticals (Nasdaq: BCRX) announced results from the completed Phase IIa trial of BCX-4208 in patients with moderate to severe plaque psoriasis. Consistent with interim findings reported in May 2008, this study of BCX-4208, a potent, rationally designed, orally available purine nucleoside phosphorylase (PNP) inhibitor, met its primary objectives of safety and tolerability.
|
Medarex Announces Presentations At The 33rd Congress Of The European Society For Medical Oncology
Sep 05, 2008 -- Medarex, Inc. (Nasdaq: MEDX) announced that nine clinical abstracts for ipilimumab, an investigational anti-CTLA-4 antibody, in melanoma are scheduled to be the subject of presentations at the 33rd Congress of the European Society for Medical Oncology (ESMO) being held September 12-16, 2008 in Stockholm.
|
Research Questions Inequality Of Skin Cancer Monitoring For Transplant Patients
Sep 05, 2008 -- Kidney transplant patients, one of the most at-risk groups for skin cancer, are not being sufficiently educated or monitored for the disease, according to new research. Kidney transplant recipients are three times more likely to develop skin cancer than people who have not received a transplant. 30 percent of UK renal (kidney) transplant recipients (RTRs) will go on to develop non-melanoma skin cancer, the most common type, within 10 years.
|
National Pediculosis Association Marks 25 Years Of Advocating Important Message: 'It's Not About Lice, It's About Kids'
Sep 04, 2008 -- A lot can change in 25 years, but the National Pediculosis Association 's commitment to protecting children from the misuse and abuse of pesticides has never wavered. Each year NPA's signature outreach, the All Out Comb Out, coincides with its sponsorship of National Head Lice Prevention Month and the back to school season. The National Pediculosis Association's message is timeless, as relevant now as it was 25 years ago.
|
UF'S Burn Center Tests Virtual Reality Disaster Training
Sep 04, 2008 -- Forget the stethoscope - the video game controller could be the newest item you find in your doctor's black bag. Medical trauma doctors and nurses throughout Florida are testing an interactive training program developed by University of Florida experts to model a mass disaster involving patients with burn injuries. The Web-based program goes live for testing this October.
|
Vitamin D Has Potential To Ward Off Disease, Reports Harvard Women's Health Watch
Sep 04, 2008 -- September brings the end of summer in the northern hemisphere and, for many, that means getting less sunshine. Our skin uses the sun's rays to make vitamin D. Without it, the body can't absorb dietary calcium, so it steals calcium from bones, increasing the risk of osteoporosis and fractures. But missing out on the "sunshine vitamin" has consequences for more than just bone health, reports the September 2008 issue of Harvard Women's Health Watch.
|
European Congress On Anti-Aging And Aesthetic Medicine (ECAAAM)
Sep 04, 2008 -- The European Congress on Anti-aging and Aesthetic Medicine, ECAAAM, is a newly launched European event that caters specifically for European medical professionals, scientists and medical personnel working in the anti-aging, aesthetic and preventive medicine sectors. The event is created to provide medical professionals with the training and education they need to handle age-related dysfunctions, disorders and diseases.
|
|